DrugPatentWatch Database Preview
Email this page to a colleague
« Back to Dashboard
Kalexate is a drug marketed by Kvk Tech and is included in one NDA.
The generic ingredient in KALEXATE is sodium polystyrene sulfonate. There are one thousand four hundred and seventy-two drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the sodium polystyrene sulfonate profile page.
A generic version of KALEXATE was approved as sodium polystyrene sulfonate by CMP PHARMA INC on January 19th, 1989.
|Applicant||Tradename||Generic Name||Dosage||NDA||Approval Date||TE||Type||RLD||RS||Patent No.||Patent Expiration||Product||Substance||Delist Req.||Exclusivity Expiration|
|Kvk Tech||KALEXATE||sodium polystyrene sulfonate||POWDER;ORAL, RECTAL||040905-002||Apr 3, 2015||RX||No||No||⤷ Try it Free||⤷ Try it Free||⤷ Try it Free|
|Kvk Tech||KALEXATE||sodium polystyrene sulfonate||POWDER;ORAL, RECTAL||040905-001||Mar 30, 2009||AA||RX||No||Yes||⤷ Try it Free||⤷ Try it Free||⤷ Try it Free|
|>Applicant||>Tradename||>Generic Name||>Dosage||>NDA||>Approval Date||>TE||>Type||>RLD||>RS||>Patent No.||>Patent Expiration||>Product||>Substance||>Delist Req.||>Exclusivity Expiration|